Gravibinan 2ml

Gravibinan 2ml Injection for Preventing Preterm Birth

Gravibinan 2ml injection is a medication used to prevent preterm birth in pregnant women who have a history of delivering their babies too early or are at risk of premature delivery. It is commonly prescribed to women who have had previous preterm births or are experiencing conditions that could lead to early labor.

Uses

• Prevention of Preterm Birth: Gravibinan is specifically designed to help pregnant women avoid preterm birth. It is administered as an intramuscular injection, typically starting at 16 to 20 weeks of gestation and continuing until 37 weeks of gestation or delivery, whichever comes first.
• Treatment of Gynecological Disorders: This injection may also be used to manage certain gynecological conditions or disorders, as determined by a healthcare provider.

Side Effects

Some common side effects of Gravibinan 2ml injection include:

• Urge to cough.
• Respiratory distress.
• Coughing fits.
• Nausea.
• Diarrhea.
• Swelling or pain at the injection site.
• Headache.

Serious side effects include:

• Yellowing of the eyes or skin (jaundice).
• Sleeping problems.
• Severe headache.
• Swelling of ankles or feet.
• Blurred vision.
• Mental or mood changes.

Warnings and Precautions

• Medical History Disclosure: Share a complete medical history, including conditions like unusual vaginal bleeding, heart problems, and other relevant issues.
• Allergy Information: Inform the doctor about any known allergies to the active ingredients in this injection.
• Avoid Alcohol or Marijuana: Refrain from consuming alcohol or marijuana while using this medication.
• Avoid Specific Medications: Certain medications should not be taken concurrently with Gravibinan; consult with a healthcare professional.
• Monitoring for Side Effects: Be vigilant for side effects and promptly report any unusual or severe reactions to the healthcare provider.
• Pregnancy and Breastfeeding: It is safe during pregnancy for preventing preterm birth but not recommended during breastfeeding.

Precautions

Progestins may decrease glucose tolerance, and blood glucose concentration should be monitored in diabetic users.

When Not to Use

Gravibinan is contraindicated in cases of excessive thickening of the womb lining, breast cancer, thrombosis, liver disease, and allergic responses.

Dosage

The dosage of Gravibinan injection can vary depending on the specific medical condition being treated and the individual’s response to the medication. For the prevention of preterm birth, a common dosage regimen is 250 milligrams (mg) administered once weekly starting at 16 to 20 weeks of gestation and continuing until 37 weeks of gestation or delivery, whichever occurs first.

Price in Pakistan

Gravibinan 2ml injections are available for Rs. 522.78 in Pakistan.